FIELD: medicine, ophthalmology.
SUBSTANCE: in addition to well-known medicinal therapy one should introduce 1.5%-derinate solution per 0.5 ml under temporal skin from both sides in one syringe with 0.5 ml 2%-lidocaine solution, and, also, i/m per 4.0 ml daily from 5 to 10 injections, moreover, 0.25%-derinate solution should be introduced simultaneously intranasally and into conjunctival cavity 6 times daily. Improved result has been achieved due to immunomodulating properties of derinate.
EFFECT: higher efficiency of therapy.
2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT AND THERAPY OF EXUDATIVE OTITIS MEDIA | 2008 |
|
RU2358743C1 |
| METHOD FOR TREATING OPHTHALMIC MANIFESTATIONS OF DISEASES TRANSMITTED VIA SEXUAL INTERCOURSE | 2003 |
|
RU2259180C2 |
| SCLERA-STRENGTHENING METHOD FOR TREATING THE CASES OF INFANTINE MYOPIA WITH HIGH RISK OF PROGRESSIVE DEVELOPMENT | 1999 |
|
RU2164111C2 |
| SURGICAL METHOD FOR TREATING THE CASES OF PROGRESSIVE MYOPIA | 2003 |
|
RU2238706C1 |
| METHOD OF TREATING ISCHEMIC TYPE OF PRIMARY OPEN-ANGLE GLAUCOMA IN INDIVIDUALS WITH NEAT SIGHT | 2010 |
|
RU2438670C1 |
| METHOD FOR TREATING PROGRESSING MYOPIA | 2003 |
|
RU2257900C1 |
| METHOD FOR TREATING THE CASES OF PROGRESSIVE AND AGGRAVATED MYOPIA | 2003 |
|
RU2238704C1 |
| METHOD FOR TREATING MILD AND MODERATE MYOPIA | 2020 |
|
RU2737494C1 |
| METHOD FOR TREATING AND PREVENTING THE CASES OF PROGRESSIVE MYOPIA | 1997 |
|
RU2145827C1 |
| METHOD FOR PREVENTION OF MYOPIA PROGRESSION | 2010 |
|
RU2444338C1 |
